Latest News
Micron's stock is off its all-time high, but not for long.
Via The Motley Fool · September 15, 2026
Biogen (NASDAQ:BIIB) is reshaping its business around a broader mix of neuroscience, immunology, kidney disease and ophthalmology assets, President and CEO Chris Viehbacher said during a Morgan Stanley event. The company expects a series of late-stage clinical readouts to begin as soon as next quart
Via MarketBeat · September 15, 2026
Citadel, Ken Griffin's hedge fund, materially increased its stake in AbbVie; here's why you may want to follow that lead.
Via The Motley Fool · September 14, 2026
AI fears are mounting.
Via The Motley Fool · September 14, 2026

XAUUSD: SELL 4306.11-4360.01, TP1-4252.21, TP2-4086.71.A month without swaps on majors! Learn moreLong-term trend: long. The maximum accumulation of volume
Via Talk Markets · September 15, 2026
There are now over a dozen publicly traded companies with market caps exceeding $1 trillion.
Via The Motley Fool · September 14, 2026
Generating sizable dividends from stocks can help achieve passive income goals or supplement income in retirement.
Via The Motley Fool · September 14, 2026
Viking Therapeutics (NASDAQ:VKTX) said its obesity drug candidate VK2735 has advanced into Phase 3 development following Phase 2 results that showed approximately 15% weight loss from baseline after 13 weeks at the highest tested dose.
Speaking at the Morgan Stanley Global Healthcare Conference, Pr
Via MarketBeat · September 14, 2026
Homebuilder Lennar (NYSE:LEN) will be reporting results this Wednesday after market hours. Here’s what you need to know. Lennar missed analysts’ revenue expe...
Via StockStory · September 14, 2026
Record revenue and margin gains as company diversifies into aerospace and edge data centers.
Via The Motley Fool · September 14, 2026
International divestiture deal and $16M cost savings reshape portfolio strategy.
Via The Motley Fool · September 14, 2026

8:45 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List.https://buyingbreakouts.com/mon-9-14-md-remain
Via Talk Markets · September 14, 2026

8:40 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List.https://buyingbreakouts.com/mon-9-14-oii-trigg
Via Talk Markets · September 14, 2026

8:50 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List.https://buyingbreakouts.com/mon-9-14-eix-the-1
Via Talk Markets · September 14, 2026
Motley Fool recommends that investors own 50 stocks for diversification, with results to back that up.
Via The Motley Fool · September 14, 2026

8:55 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch Listhttp://buyingbreakouts.com/mon-9-14-ndsn-a-brea
Via Talk Markets · September 14, 2026

Revolutionize your spine care with the cutting-edge Robotic Endoscopic Spine Surgery, expertly performed by the acclaimed Spine Surgeon, Dr. Andrew Chung.
Via Talk Markets · September 14, 2026

8:54 PM – Here is our latest chart update for this recent breakout from our Traditional BreakOuts Watch List.https://buyingbreakouts.com/mon-9-14-oke-volat
Via Talk Markets · September 14, 2026
Walking into a Brazilian Jiu-Jitsu academy for the first time can feel exciting and slightly intimidating. You may be wondering whether you are fit enough,
Via Talk Markets · September 14, 2026
It's not too late to catch up if you're behind your peers. Just don't tarry if you are.
Via The Motley Fool · September 14, 2026
Regeneron Pharmaceuticals (NASDAQ:REGN) outlined growth opportunities for Dupixent, pipeline catalysts for cemdisiran and continued commercial momentum for EYLEA HD during the Morgan Stanley Global Healthcare Conference.
Marion McCourt, Regeneron’s EVP and head of commercial, said Dupixent’s growth
Via MarketBeat · September 14, 2026
The 4% rule is a helpful estimate, but a three-layer income plan shows exactly where your next retirement payment comes from.
Via The Motley Fool · September 14, 2026
The best investments are sometimes the simplest.
Via The Motley Fool · September 14, 2026
Bird Construction stock has delivered impressive gains. Here’s how its growing project pipeline could support the next phase of infrastructure growth.
Via The Motley Fool · September 14, 2026
The 2026 TSX30 list features five Canadian technology companies whose average return reached an extraordinary 981%.
Via The Motley Fool · September 14, 2026